Jafra Capital Management’s Amgen AMGN Stock Holding History

Jafra Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,000	Closed	-$2.8M	–	88
2017 Q3	$2.8M	Buy	+15,000	New	+$2.66M	1.04%	40

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Jafra Capital Management's AMGN Position: Q4 2017 in Review

Jafra Capital Management sold out of Amgen (AMGN) in Q4 2017, closing a stake of 15,000 shares — an estimated $2.8M sold.

Jafra Capital Management first reported a position in AMGN in Q3 2017 and held it in 1 quarter. The position peaked at $2.8M in Q3 2017. 1,734 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

Jafra Capital Management reported no remaining Amgen position as of Q4 2017 after selling out during the quarter.
Jafra Capital Management sold 15,000 Amgen shares in Q4 2017, an estimated $2.8M.
Jafra Capital Management first reported a position in Amgen in Q3 2017 and held it in 1 quarter.
Jafra Capital Management's Amgen position peaked at $2.8M in Q3 2017.
1,734 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on Jafra Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.